Microfabricated nanochannel implantable drug delivery devices: Trends, limitations and possibilities

Expert Opinion on Drug Delivery

Volumn 3, Issue 4, 2006, Pages 479-487

  Gardner, Phyllis ^a  

^a Department of Medicine ^*  (United States)

Author keywords

BioMEMS; Drug delivery; Implantable; Microchips; Microfabrication; Microparticles; Nanochannels; Nanopores

Indexed keywords

NANOMATERIAL; SILICON;

CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG IMPLANT; HUMAN; INSTRUMENTATION; METHODOLOGY; REVIEW;

DRUG DELIVERY SYSTEMS; DRUG IMPLANTS; HUMANS; MICROCHEMISTRY; NANOSTRUCTURES; SILICON;

EID: 33847796211     PISSN: 17425247     EISSN: None     Source Type: Journal    
DOI: 10.1517/17425247.3.4.479     Document Type: Review

References (51)

1. LAVAN DA, MCGUIRE T, LANGER R: Small-scale systems for in vivo drug delivery. Nat. Biotechnol. (2003) 21:1184-1191. (Pubitemid 37186175)
2. POLLA DL, ERDMAN AG, ROBBINS WP et al.: Microdevices in medicine. Ann. Rev. Biomed. Eng. (2000) 2:551-576.
3. RAZZACKI SZ, THWAR PK, YANG M, UGAZ VM, BURNS MA: Integrated Microsystems for controlled drug delivery. Adv. Drug Deliv. Rev. (2004) 56:185-198. •• Excellent overall review of microfabricated systems for drug delivery, including benefits derived from the photolithographic techniques of the silicon chip industry.
4. SANTINI JT Jr, CIMA MJ, LANGER R: A controlled-release microchip. Nature (1999) 397:335-338. • Original article describing the microchip technology, designed to deliver on-demand micro-dosage of one or more therapeutic agents from an implanted device.
5. WILKINSON M: Microelectromechanical systems in drug delivery. Med. Device Technol. (2003) 14:21-24.
6. RICHARDS GRAYSON AC, SCHEIDT SHAWGO R, LI Y, CIMA MJ: Electronic MEMS for triggered delivery. Adv. Drug Deliv. Rev. (2004) 56:173-184. (Pubitemid 38114929)
7. MALONEY JM, UHLAND SA, POLITO BF, SHEPPARD NF Jr, PELTA CM, SANTINI JT Jr: Electrothermally activated microchips for implantable drug delivery and biosensing. J. Control. Release (2005) 5:244-255. (Pubitemid 41737268)
8. RICHARDS GRAYSON AC, CIMA MJ, LANGER R: Molecular release from a polymeric microreservoir device: influence of chemistry, polymer swelling, and loading on device performance. J. Biomed. Mater. Res. A. (2004) 69:502-512. (Pubitemid 38668176)
9. ITO Y, HASUDA H, MORIMATSU M, TAKAGI N, HIRAI Y: A microfabrication method of a bioerodable polymer chip for a controlled release system. J. Biomater. Sci. Plym. Ed. (2005) 16:949-955. (Pubitemid 41038820)
10. LI Y, SHAWGO RS, TYLER B et al.: In vivo release from a drug delivery MEMS device. J. Control. Release (2004) 24:211-219. (Pubitemid 39491273)
11. LI Y, HO DUC HL, TYLER B et al.: In vivo delivery of BCNU from a MEMS device to a tumor model. J. Control. Release (2005) 18:138-145. • Example of in vivo application of microchip device in a rat tumour model.
12. VOSKERICIAN G, SHAWGO RS, HILTNER PA, ANDERSON JM, CIMA MJ, LANGER R: In vivo inflammatory and wound healing effects of gold electrode voltammetry for MEMS micro-reservoir drug delivery device. IEEE Trans. Biomed. Eng. (2004) 51:627-635. (Pubitemid 38375138)
13. LESINSKI GB, SHARMA S, VARKER KA, SINHA P, FERRARI M, CARSON WE III: Release of biologically functional interferon-alpha from a nanochannel delivery system. Biomedical Microdev. (2005) 7:71-79. (Pubitemid 40613133)
14. DESAI T, HANSFORD D, FERRARI M: Micromachined interfaces: new approaches in cell immunoisolation and biomolecular separation. Biomol. Eng. (2000) 17:23-36. • Original description of a microfabricated membrane serving as a means for diffusion control after biomolecular separation.
15. MARTIN F, WALCZAK R, BOIARSKI A et al.: Tailoring width of microfabricated nanochannels to solute size can be used to control diffusion kinetics. J. Control. Release (2005) 102:123-133. •• Original research on the mechanism of zero-order release by the microfabricated membrane in the nanopore pump.
16. GUPTA V, NIVARTHI SS, KEFFER D, MCCORMICK AV: Evidence of single-file diffusion in zeolites. Science (1996) 272:702-704.
17. CLARK LA, YE GT, SNURR RQ: Molecular traffic control in a nanoscale system. Phys. Rev. Letters (2000) 84:2893-2896. (Pubitemid 40598925)
18. WEI Q, BECHINGER C, LEIDERER P: Single-file diffusions of colloids in one-dimensional channels. Science (2000) 287:625-627. (Pubitemid 30070904)
19. PUTNEY SD, BURKE PA: Improving protein therapeutics with sustained-release formulations. Nat. Biotechnol. (1998) 16:153-157. (Pubitemid 128723585)
20. KIM HK, PARK TG: Microencapsulation of human growth hormone within biodegradable polyester microspheres: protein aggregation stability and incomplete release mechanism. Biotechnol. Bioeng. (1999) 65:659-667.
21. MARTIN FJ, GROVE C:. Microfabricated drug delivery systems: concepts to improve clinical benefit. Biomed. Microdev. (2001) 3:97-108. •• Excellent overall review of microfabricated systems.
22. LI J, STEIN D, MCMULLAN C, BRANTON D, AZIZ MJ, GOLOVCHENKO JA: Ion-beam sculpting at nanometer length scales. Nature (2001) 412:166-169. (Pubitemid 32674708)
23. SAMBANIS A, PAPAS KK, FLANDERS PC, LONG RC Jr, KANG H, CONSTANTINIDIS I: Toward the development of a bioartificial pancreas: immunoisolation and NMR monitoring of mouse insulinomas. Cytotechnology (1994) 15:351-363.
24. BRETZEL RG, ECKHARD M, BRENDEL MD: Pancreatic islet and stem cell transplantation: new strategies in cell therapy of diabetes mellitus. Panminerva Med. (2004) 46:25-42. (Pubitemid 39090617)
25. AMERICAN DIABETES ASSOCIATION: Standards of medical care for patients with diabetes mellitus. Diabetes Care (2004) 27(Suppl. 1):S15-S35.
26. AMERICAN DIABETES ASSOCIATION: Implications of the diabetes control and complications trial. Diabetes Care (2003) 26(Suppl. 1):S25-S27. (Pubitemid 36928955)
27. HAFIZ MM, FARADJI RN, FROUD T et al.: Immunosuppression and procedure-related complications in 26 patients with Type 1 diabetes mellitus receiving allogeneic islet cell transplantation. Transplantation (2005) 27:1718-1728. (Pubitemid 43053997)
28. DE VOS P, MARCHETTI P: Encapsulation of pancreaqtic islets for transplantation in diabetes: the untouchable islets. Trends Mol. Med. (2002) 8:363-366. (Pubitemid 34826718)
29. DESAI TA, CHU WH, TU JK, BEATTIE GM, HAYEK A, FERRARI M: Microfabricated immunoisolating biocapsules. Biotechnol. Bioeng. (1998) 57:118-120. • Original description of the microfabricated immunoisolating biocapsules for cellular implantation.
30. LEONI L, DESAI TA: Nanoporous biocapsules for the encapsulation of insulinoma cells: biotransport and biocompatibility considerations. IEEE Trans. Biomed. Eng. (2001) 48:1335-1341. (Pubitemid 32988574)
31. LEONI L, DESAI TA: Micromachined biocapsules for cell-based sensing and delivery. Adv. Drug Deliv. Rev. (2004) 56:211-229. (Pubitemid 38114932)
32. DESAI TA, WEST T, COHEN M, BOIARSKI T, RAMPERSAUD A: Nanoporous Microsystems for islet cell replacement. Adv. Drug Deliv. Rev. (2004) 56:1661-1673. (Pubitemid 39177695)
33. SMITH C, KIRK R, WEST T et al.: Diffusion characteristics of microfabricated silicon nanopore membranes as immunoisolation membranes for use in cellular therapeutics. Diabetes Technol. Ther. (2005) 7:151-162. (Pubitemid 40354585)
34. DESAI TA, CHU WH, RASI G, SINBALDI-VALLEBONA P, GUARINO E, FERRARI M: Microfabricated biocapsules provide short-term immunoisolation of insulinoma xenografts. Biomed. Microdev. (1998) 1:131-138. (Pubitemid 129645134)
35. FERRARI M: Cancer nanotechnology: Opportunities and challenges. Nat. Rev. Cancer (2005) 5:161-171. (Pubitemid 40314948)
36. DAVIS SS: Biomedical applications of nanotechnology-implications for drug targeting and gene therapy. Trends Biotechnol. (1997) 15:217-324.
37. FUJIMASA I: Micromachining technology and biomedical engineering. Appl. Biochem. Biotechnol. (1993) 38:233-242.
38. YUAN F, DELLIAN M, FUKUMURA D et al.: Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. Cancer Res. (1995) 55:3752-3756.
39. ISHIDA O, MARUYAMA K, SASAKI K, IWATSURU M: Size-dependent extravasation and interstitial localization of polyethyleneglycol liposomes in solid tumor-bearing mice. Int. J. Pharm. (1999) 190:49-56. (Pubitemid 29467471)
40. HOLASH J, WIEGAND SJ, YANCOPOULOS GD: New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF. Oncogene (1999) 18:5356-5362. (Pubitemid 29462372)
41. MARTIN FJ, MELNIK K, WEST T et al.: Acute toxicity of intravenously administered microfabricated silicon dioxide drug delivery particles in mice: preliminary findings. Drugs R D (2005) 6:71-81. (Pubitemid 40500173)
42. SHENOY D, LITTLE S, LANGER R, AMIJI M: Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs. 1. In vitro evaluations. Mol. Pharm. (2005) 2:357-366. (Pubitemid 41503676)
43. SHENOY D, LITTLE S, LANGER R, AMIJI M: Poly(ethylene oxie)-modified ply(beta-amino-ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs. Part 2. In vivo distribution and tumor localization studies. Pharm Res. (2005) 22:2107-2114. (Pubitemid 41821590)
44. MURALI M, YEO SH: Rapid biocompatible micro device fabrication by micro electro-discharge machining. Biomed. Microdevices (2004) 6:41-45. (Pubitemid 38324862)
45. ZIAIE B, BALDI A, LEI M, GU Y, SIEGEL RA: Hard and soft micromachining for BioMEMS: review of techniques and examples of applications in microfluidics and drug delivery. Adv. Drug Deliv. Rev. (2004) 56:145-172. (Pubitemid 38114928)
46. UNGER MA, CHOU H-P, THORSEN T, SCHERER A, QUAKE SR: Monolithic microfabricated valves and pumps by multilayer soft lithography. Science (2000) 288:113-116. (Pubitemid 30203039)
47. PIZZI M, DE MARTIIS OD, GRASSO V: Fabrication of self assembled micro reservoirs for controlled drug release. Biomed. Microdevices (2004) 6:155-158. (Pubitemid 38801857)
48. http://www.alza.com ALZA Corp. website.
49. http://www.mchips.com MicroCHIPS Technology website.
50. http://www.iq-micro.com IQ Micro, Inc. website.
51. http://www.hawkassociates.com/iqmicro/text.htm IQ Micro, Inc. announces international licensing program for proprietary microfluidic technology.